Jessica Ann Thompson, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 400 Water Ave, Hillsboro, WI 54634 Phone: 608-464-3575 Fax: 608-464-3576 |
Michelle Gardner, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 400 Water Ave, Hillsboro, WI 54634 Phone: 608-489-8000 |
News Archive
RCSI University of Medicine and Health Sciences and LEO Pharma have partnered to better understand the role of a blood clotting protein in the spread of breast cancer.
A team of scientists from The Scripps Research Institute and the University of California, San Diego (UCSD) have developed a novel technique to observe previously unknown details of how folded structures are formed from an intrinsically disordered protein. The insights could help scientists to better understand the mechanism of plaque formation in neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.
Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company's proprietary Pharmacosurgery product being developed for all ILR, including cataract surgery and refractive lens exchange.
› Verified 5 days ago